-
China's anti Ebola drug "jk-05" is expected to be put into Africa in batches
Time of Update: 2014-09-01
In recent days, the Ebola epidemic in West Africa seems to be showing no signs of improvement, and concerns about the global spread of the Ebola epidemic are increasing China played an important role
-
Apatinib, a heavyweight new drug of Hengrui medicine, has entered the three in one comprehensive review
Time of Update: 2014-09-01
Apatinib is the first molecular targeted drug for advanced gastric cancer in the world, and it is also the first variety of Hengrui medicine to be listed in the research and development of new drugs I
-
Top 20 drug registration queue in August 2014
Time of Update: 2014-09-01
Serial No.: the serial no of the queue where the acceptance No is located on August 31, 2014 goes forward: Serial No of the queue on August 31, 2014 - Serial No of the queue on August 1, 2014 1, IND S
-
"Jk-05", an anti Ebola drug of the Academy of Military Medical Sciences, was approved by the army as a special drug
Time of Update: 2014-08-29
Today, the reporter learned from the Academy of Military Medical Sciences that the drug "jk-05", developed by the Institute of microbial epidemiology of the Academy for Ebola virus and lasting for fiv
-
Lepu medical acquires levosimendan injection, a new drug of haihetianhuo
Time of Update: 2014-08-29
Lepu medical announced on August 26 that the company plans to acquire 71.39% of the equity of Beijing haihetian Technology Development Co., Ltd for 125 million yuan to enter the field of heart failure
-
Warwick's first drug like riluzole reduces the cost of ALS patients by more than 50%
Time of Update: 2014-08-28
Overnight, the "ALS ice bucket challenge" campaign was launched to appeal to the public to pay attention to ALS (amyotrophic lateral sclerosis, commonly known as "progressive frostbite") as a rare dis
-
Phase I clinical study of azvudine (FNC), an anti HIV drug, showed significant effect
Time of Update: 2014-08-27
According to the website of the Chinese Academy of Sciences, nucleoside reverse transcriptase inhibitors (NRTIs) are an important part of anti HIV drugs, and also constitute the basic component of eff
-
New progress in clinical research of compound naphthoquine phosphate tablets
Time of Update: 2014-08-27
It is understood that the compound naphthoquine phosphate tablet (Arco ®) is an oral preparation exclusively produced by the company for the treatment of malaria The results of the Indonesian children
-
Four first-class new drugs of Haizheng Pharmaceutical Co., Ltd. have successfully carried out clinical trials in the United States and China
Time of Update: 2014-08-27
Among them, the world's second cholesterol absorption inhibitor, hazel mAb, has completed phase I clinical research in the United States and is conducting phase II clinical research, which is expected
-
Green leaf Pharmaceutical Co develops poziotinib with South Korea and the United States
Time of Update: 2014-08-25
According to the agreement, LVYE pharmaceutical is granted the exclusive right to develop, produce and commercialize poziotinib in China in the name of the group, while Korea and the United States res
-
It is estimated that the approval document for the production of lipanol injection of Beilu pharmaceutical will be obtained within this year
Time of Update: 2014-08-25
Wang Daixue, chairman of the board of directors, added that iodophor injection is still in the stage of review and queuing, "only one place ahead of last week's position" The API of the preparation wa
-
Baiyunshan Jinge raw material production was approved and won the first place of Viagra in China
Time of Update: 2014-08-25
After the expiration of Pfizer vanico (commonly known as "Viagra") patent, Baiyunshan (600332) "Viagra" -- "Jinge" has always attracted social attention Following the approval of "Jinge" preparation p
-
Rapid growth of clinical trial consulting business of tag
Time of Update: 2014-08-21
Key investment points: 1 The company's leading position in the domestic cro industry will be further consolidated At present, the concentration of cro industry in China is higher than that in the Unit
-
Pfizer officially submits the application for new breast cancer drug palbociclib to Da
Time of Update: 2014-08-19
This time, Pfizer submitted the combination of palbociclib and letrozole The indications were estrogen receptor positive and HER2 negative advanced breast cancer The application is based on the compan
-
Opening up the blindness of evidence-based medicine research on Shensong Yangxin capsule of Yiling pharmaceutical
Time of Update: 2014-08-18
The results showed that: compared with the placebo group (233 cases), Shensong Yangxin Capsule could significantly increase the decrease rate of ventricular premature times in 24-hour Holter, improve
-
Shenwei pharmaceutical synovitis granules obtained the patent for invention
Time of Update: 2014-08-18
Shenwei synovitis granule is a unique and innovative modern Chinese medicine for synovitis, which fills in the blank of the treatment field of "western medicine relies on surgery, Chinese medicine has
-
Guizhou bailing anti hepatitis B new drug "tefentai" clinical research officially launched
Time of Update: 2014-08-17
In 1999, the clinical research of tifentai, a new anti hepatitis drug, was officially launched Professor Liang Guangyi, the key research laboratory of natural product chemistry of Guizhou Academy of S
-
Taiwan funded Nanjing norite pharmaceutical R & D base is officially listed in Jiangsu life science and Technology Innovation Park
Time of Update: 2014-08-16
Opening ceremony of Nanjing norite Pharmaceutical Technology Co., Ltd The company is mainly engaged in the research and development of special high-quality and long-term new drug products In the first
-
The first anniversary of new drug "Kemena" of Beida Pharmaceutical Co., Ltd. being included in Zhejiang medical insurance
Time of Update: 2014-08-14
Five experts from Beida's national "thousand talents plan" gathered at Kemena's achievement conference to talk about the "pacesetter" in the research and development of domestic anti-cancer drugs in H
-
A new drug of Zizhu pharmaceutical, mifepristone tablet (10mg), completed a multicenter clinical study
Time of Update: 2014-08-13
It is understood that hysteromyoma is the most common benign tumor of female genitalia, which is common in women between 30 and 50 years old According to the health statistics yearbook of 2013, in Chi
